Skip to main content
. 2017 Nov 27;55(12):3366–3373. doi: 10.1128/JCM.00865-17

FIG 3.

FIG 3

Blockade titers against GII.4 P domain-HBGA (A) and GII.17 P domain-HBGA attachments (B) using human sera collected from a GII.17 outbreak. Acute- and convalescent-phase serum samples (5 asymptomatic controls and 10 symptomatic cases) were collected during an outbreak. The fold increases from acute- to convalescent-phase serum in blockade titers (green columns) were determined (right-hand y axis).